Please follow the dosing instructions for Sucraid® carefully.
If you have been diagnosed with CSID, ask your GI doctor if Sucraid® is right for you.
Dosing Instructions for Sucraid® single-use containers:
The contents of the Sucraid® 2-mL single-use container should be diluted in 4 ounces of water, milk, or infant formula. Patients should consume:
It is recommended that approximately half the dosage be taken at the beginning of each meal or snack and the remainder of the dosage taken during the meal or snack. Sucraid® acts on the food you eat while it is in your gastrointestinal (GI) tract. Therefore, it is important that Sucraid® be taken when you are eating.
If you still have some symptoms after starting therapy with Sucraid®, your doctor may recommend avoiding starchy foods for several weeks and then gradually adding back foods containing starch while monitoring your GI symptoms.
Please refer to the Prescribing Information and Instructions for Use for full dosing instructions.
Watch this video to learn how to administer the
Sucraid® single-use containers.
The following should be noted with regards to administration and storage of Sucraid®:
Dosing instructions for Sucraid® single-use containers:
Traveling by plane with Sucraid® can also prove to be challenging. The U.S. Transportation Security Administration (TSA) permits “prescription liquid medications and other liquids needed by persons with disabilities and medical conditions. This includes all prescription and over-the-counter medications. This also includes gels or frozen liquids needed to cool disability- or medically-related items used by persons with disabilities or medical conditions.” Sucraid® can go through the X-ray machine as part of the security process without the scan affecting the ability of Sucraid® to continue working.
People have found that the burden of traveling with Sucraid® is reduced when a physician provides them with a Letter of Medical Necessity. The Letter of Medical Necessity should include the following information:
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.
Sucraid® (sacrosidase) Oral Solution is an enzyme replacement therapy for the treatment of genetically determined sucrase deficiency, which is part of
Congenital Sucrase-Isomaltase Deficiency (CSID).